Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRA | P25101 | 1/20 | 0.37 |
| ▸ | ABCC9 | O60706 | 6/20 | 0.34 |
| ▸ | TDP2 | O95551 | 1/20 | 0.34 |
| ▸ | MAT2A | P31153 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | G6PD | P11413 | 1/20 | 0.31 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17703190 | 0.91 | ABCC9 (0.32) | ABCC9TDP2G6PDPGR | |
| SCHEMBL17703192 | 0.87 | ABCC9 (0.33) | ABCC9PGR | |
| SCHEMBL17703194 | 0.87 | CYP1A2 (0.36) | ABCC9TDP2MEN1LMNAKMT2A | |
| SCHEMBL17703225 | 0.86 | ABCC9 (0.33) | ABCC9LMNAL3MBTL1G6PDPGR | |
| SCHEMBL17703204 | 0.85 | ALDH1A3 (0.35) | ABCC9PGR | |
| SCHEMBL17703201 | 0.85 | HTR6 (0.35) | G6PDPGR | |
| SCHEMBL17703197 | 0.85 | ABCG2 (0.34) | ABCC9TDP2MEN1LMNAKMT2A | |
| SCHEMBL17704032 | 0.85 | ABCC9 (0.34) | ABCC9G6PDPGR | |
| SCHEMBL17703193 | 0.84 | PIK3CD (0.32) | ABCC9PGR | |
| SCHEMBL17703198 | 0.84 | ABCG2 (0.36) | ABCC9MEN1LMNAKMT2APGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9722187-B2 | Compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-08-01 | — | — | US | disclosed |
| US-9722187-B2 | Compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-08-01 | — | — | US | disclosed |
| US-20160118599-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-04-28 | — | — | US | disclosed |
| US-20160118599-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160118599-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, AOX1, CYP1A1 | EDNRA 3989/4885ABCC9 2989/4885TDP2 3475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.